Spyre Therapeutics, Inc.
(SYRE - NASDAQ)
71,44 USD
📋 Profilo Aziendale

Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

|